Alteogen Inc
KOSDAQ:196170

Watchlist Manager
Alteogen Inc Logo
Alteogen Inc
KOSDAQ:196170
Watchlist
Price: 300 500 KRW 1.18%
Market Cap: 16T KRW
Have any thoughts about
Alteogen Inc?
Write Note

Relative Value

The Relative Value of one Alteogen Inc stock under the Base Case scenario is 56 695 KRW. Compared to the current market price of 300 500 KRW, Alteogen Inc is Overvalued by 81%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
56 695 KRW
Overvaluation 81%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
1
vs Industry
13
Median 3Y
68.4
Median 5Y
69.3
Industry
7.7
Forward
209.1
vs History
vs Industry
0
Median 3Y
-102.1
Median 5Y
-102.1
Industry
22.7
Forward
2 171.3
vs History
22
vs Industry
0
Median 3Y
-219
Median 5Y
-69.4
Industry
21.6
vs History
1
vs Industry
Median 3Y
-35.5
Median 5Y
-43
Industry
25.2
vs History
1
vs Industry
0
Median 3Y
17.1
Median 5Y
17.7
Industry
2.5
vs History
1
vs Industry
12
Median 3Y
64.1
Median 5Y
66.2
Industry
7.7
Forward
207.2
vs History
6
vs Industry
5
Median 3Y
327
Median 5Y
186.8
Industry
9
vs History
vs Industry
0
Median 3Y
-158
Median 5Y
-140.5
Industry
4.2
Forward
802.1
vs History
vs Industry
100
Median 3Y
-135.6
Median 5Y
-122.9
Industry
4.1
Forward
-2 310.6
vs History
22
vs Industry
0
Median 3Y
-207.5
Median 5Y
-63
Industry
5.7
vs History
vs Industry
Median 3Y
-65.4
Median 5Y
-71.8
Industry
3.6
vs History
14
vs Industry
3
Median 3Y
32.8
Median 5Y
41.4
Industry
4.6

Multiples Across Competitors

Competitors Multiples
Alteogen Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
KR
Alteogen Inc
KOSDAQ:196170
15.8T KRW 214.6 -5 493 -5 662.9 -2 743.4
FR
Pharnext SCA
OTC:PNEXF
6T USD 37 797 580.3 -179 646.3 -218 147.8 -215 658.5
US
Abbvie Inc
NYSE:ABBV
320.1B USD 5.8 63 15.6 24.1
US
Amgen Inc
NASDAQ:AMGN
147.4B USD 4.5 34.9 16.5 31.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
119.4B USD 11.2 -248.8 24.8 26
US
Gilead Sciences Inc
NASDAQ:GILD
113.8B USD 4 903.4 10 10
US
Epizyme Inc
F:EPE
94.1B EUR 1 863.9 -475.6 -517.9 -504.1
AU
CSL Ltd
ASX:CSL
135.4B AUD 5.9 33.1 20.4 25.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
82.6B USD 6 17.8 16.2 18
US
Seagen Inc
F:SGT
39.3B EUR 18 -55.1 -59.2 -53.4
NL
argenx SE
XBRU:ARGX
34.3B EUR 18.5 -130 -104.6 -76.2
P/E Multiple
Earnings Growth
KR
Alteogen Inc
KOSDAQ:196170
Average P/E: 210.4
Negative Multiple: -5 493
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -179 646.3 N/A
US
Abbvie Inc
NYSE:ABBV
63
412%
US
Amgen Inc
NASDAQ:AMGN
34.9
73%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -248.8
42%
US
Gilead Sciences Inc
NASDAQ:GILD
903.4
75%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -475.6 N/A
AU
CSL Ltd
ASX:CSL
33.1
65%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.8
43%
US
S
Seagen Inc
F:SGT
Negative Multiple: -55.1 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -130 N/A
EV/EBITDA Multiple
EBITDA Growth
KR
Alteogen Inc
KOSDAQ:196170
Average EV/EBITDA: 17.3
Negative Multiple: -5 662.9
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -218 147.8 N/A
US
Abbvie Inc
NYSE:ABBV
15.6
29%
US
Amgen Inc
NASDAQ:AMGN
16.5
62%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24.8
43%
US
Gilead Sciences Inc
NASDAQ:GILD
10
16%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -517.9 N/A
AU
CSL Ltd
ASX:CSL
20.4
42%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.2
35%
US
S
Seagen Inc
F:SGT
Negative Multiple: -59.2 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -104.6 N/A
EV/EBIT Multiple
EBIT Growth
KR
Alteogen Inc
KOSDAQ:196170
Average EV/EBIT: 22.5
Negative Multiple: -2 743.4
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -215 658.5 N/A
US
Abbvie Inc
NYSE:ABBV
24.1
88%
US
Amgen Inc
NASDAQ:AMGN
31.3
93%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
26
44%
US
Gilead Sciences Inc
NASDAQ:GILD
10
29%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -504.1 N/A
AU
CSL Ltd
ASX:CSL
25.5
55%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18
54%
US
S
Seagen Inc
F:SGT
Negative Multiple: -53.4 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -76.2 N/A

See Also

Discover More
Back to Top